These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Japanese case of Herlitz junctional epidermolysis bullosa that initially showed a few blisters on the limited area. Yoshida K; Takada Y; Hagihara S; Masunaga T; Ishiko A J Dermatol; 2014 Apr; 41(4):351-3. PubMed ID: 24617447 [No Abstract] [Full Text] [Related]
12. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations. McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327 [TBL] [Abstract][Full Text] [Related]
13. Combination of a novel frameshift mutation (1929delCA) and a recurrent nonsense mutation (W610X) of the LAMB3 gene in a Japanese patient with Herlitz junctional epidermolysis bullosa, and their application for prenatal testing. Takizawa Y; Shimizu H; Pulkkinen L; Suzumori K; Kakinuma H; Uitto J; Nishikawa T J Invest Dermatol; 1998 Dec; 111(6):1239-41. PubMed ID: 9856852 [No Abstract] [Full Text] [Related]
14. Targeted next-generation sequencing identifies a novel mutation of LAMB3 in a Chinese neonatal patient presented with junctional epidermolysis bullosa. Wang H; Yang Y; Zhou J; Cao J; He X; Li L; Gao S; Mao B; Tian P; Zhou A Medicine (Baltimore); 2018 Dec; 97(49):e13225. PubMed ID: 30544381 [TBL] [Abstract][Full Text] [Related]